已收录 268921 条政策
 政策提纲
  • 暂无提纲
Antihypertensive effect of telmisartan versus perindopril in hypertensive patients
[摘要] OBJECTIVE: We performed this meta-analysis determining the antihypertensive effect of telmisartan versus perindopril in patients with essential hypertension. BACKGROUND: The comparison of antihypertensive effects between telmisartan and perindopril were controversial. METHODS: Pubmed, Web of Science, and Cochrane Central were searched for all published studies. 0.05). The reduction of diastolic BP (DBP) treated with telmisartan was greater than perindopril in these patients (WMD ‒2.05 (95% CI, ‒2.60, ‒1.49) mm Hg, p < 0.001). Considering the effects of different doses on BP reduction, a sub-analysis was performed. The reduction of DBP treated with 40 mg/day telmisartan was greater than 4‒5 mg/day perindopril (WMD ‒2.18 (95% CI, ‒2.83, ‒1.53) mm Hg, p 0.05). CONCLUSION: The reduction of DBP is greater treated with telmisartan than perindopril in patients with essential hypertension (Tab. 2, Fig. 4, Ref. 34).
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 医学(综合)
[关键词] essential hypertension;blood pressure;telmisartan;perindopril;meta-analysis [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文